Natalia Czyżyk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Natalia Czyżyk has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Marra
Department of Organic Chemistry, University of Montpellier, Montpellier, France
1 shared publication - Anna Jakieła
Clinical Department of Clinical Oncology, 4th Military Clinical Hospital with Polyclinic in Wrocław, R. Weigla 5, 50-981 Wroclaw, Poland
1 shared publication - Elżbieta Wojaczyńska
Politechnika Wrocławska, Wydział Chemiczny
1 shared publication - Marta Ostrowska
Faculty of Chemistry, Wrocław University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wroclaw, Poland
1 shared publication - Małgorzata Lower
Faculty of Chemistry, Wrocław University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wroclaw, Poland
1 shared publication
Latest Publications
- Open Access
Recent Advances in Synthesis and Applications of Calixarene Derivatives Endowed with Anticancer Activity
Calix[n]arenes, macrocycles constituted of 4–8 phenol moieties linked through methylene bridges, are stable molecules that can be selectively functionalised at the upper or lower rim. It has already been demonstrated that calixarene derivatives can be biologically or pharmacologically active compounds. More recently, suitably functionalised calixarenes and calixarene analogues (dihomooxacalixarenes, thiacalixarenes, calix[4]resorcinols, azacalixarenes, calixpyrroles, and pillarenes) were found to act as anticancer agents, at least in in vitro assays. We are reporting on the latest progress in this research field.
Open AccessRecent Advances in Synthesis and Applications of Calixarene Derivatives Endowed with Anticancer Activity
Calix[n]arenes, macrocycles constituted of 4–8 phenol moieties linked through methylene bridges, are stable molecules that can be selectively functionalised at the upper or lower rim. It has already been demonstrated that calixarene derivatives can be biologically or pharmacologically active compounds. More recently, suitably functionalised calixarenes and calixarene analogues (dihomooxacalixarenes, thiacalixarenes, calix[4]resorcinols, azacalixarenes, calixpyrroles, and pillarenes) were found to act as anticancer agents, at least in in vitro assays. We are reporting on the latest progress in this research field.